These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1286938)

  • 1. Hydrogen fluoride catalyzed migration of side chain protecting groups onto Fmoc during solid phase peptide synthesis. Characterization by CF-FAB analysis of carboxypeptidase digestions and NMR spectroscopy.
    Grode SH; Strother DS; Runge TA; Dobrowolski PJ
    Int J Pept Protein Res; 1992 Dec; 40(6):538-45. PubMed ID: 1286938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of synthetic peptides using reversible chromatographic probes based on the Fmoc molecule.
    Ball HL; Mascagni P
    Int J Pept Protein Res; 1992 Nov; 40(5):370-9. PubMed ID: 1483831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Fmoc/solid-phase synthesis of Abu(P)-containing peptides using Fmoc-Abu(PO3Me2)-OH.
    Perich JW
    Int J Pept Protein Res; 1994 Sep; 44(3):288-94. PubMed ID: 7822106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incomplete Fmoc deprotection in solid-phase synthesis of peptides.
    Larsen BD; Holm A
    Int J Pept Protein Res; 1994 Jan; 43(1):1-9. PubMed ID: 8138344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aza-amino acid scanning of secondary structure suited for solid-phase peptide synthesis with fmoc chemistry and aza-amino acids with heteroatomic side chains.
    Boeglin D; Lubell WD
    J Comb Chem; 2005; 7(6):864-78. PubMed ID: 16283795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of affinity sorbents utilizing glutathione analogs.
    Lyttle MH; Aaron DT; Hocker MD; Hughes BR
    Pept Res; 1992; 5(6):336-42. PubMed ID: 1493361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfonation of arginine residues as side reaction in Fmoc-peptide synthesis.
    Beck-Sickinger AG; Schnorrenberg G; Metzger J; Jung G
    Int J Pept Protein Res; 1991 Jul; 38(1):25-31. PubMed ID: 1938103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical synthesis of O-thiophosphotyrosyl peptides.
    Kitas E; Küng E; Bannwarth W
    Int J Pept Protein Res; 1994 Feb; 43(2):146-53. PubMed ID: 8200732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pegylated peptides I: Solid-phase synthesis of N alpha-pegylated peptides using Fmoc strategy.
    Lu YA; Felix AM
    Pept Res; 1993; 6(3):140-6. PubMed ID: 8318745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Edman degradation sequence analysis of resin-bound peptides synthesized by 9-fluorenylmethoxycarbonyl chemistry.
    Fields CG; VanDrisse VL; Fields GB
    Pept Res; 1993; 6(1):39-47. PubMed ID: 8439735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pegylated peptides. II. Solid-phase synthesis of amino-, carboxy- and side-chain pegylated peptides.
    Lu YA; Felix AM
    Int J Pept Protein Res; 1994 Feb; 43(2):127-38. PubMed ID: 8200730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Fmoc-N-(2-hydroxy-4-methoxybenzyl)amino acids in peptide synthesis.
    Zeng W; Regamey PO; Rose K; Wang Y; Bayer E
    J Pept Res; 1997 Mar; 49(3):273-9. PubMed ID: 9151261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of protected peptide amides using the Fmoc chemical protocol. Comparison of resins for solid phase synthesis.
    Story SC; Aldrich JV
    Int J Pept Protein Res; 1992 Jan; 39(1):87-92. PubMed ID: 1353068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated Fmoc-based solid-phase synthesis of peptide thioesters with self-purification effect and application in the construction of immobilized SH3 domains.
    Mende F; Beisswenger M; Seitz O
    J Am Chem Soc; 2010 Aug; 132(32):11110-8. PubMed ID: 20662535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, isolation, and characterization of Nalpha-Fmoc-peptide isocyanates: solution synthesis of oligo-alpha-peptidyl ureas.
    Sureshbabu VV; Patil BS; Venkataramanarao R
    J Org Chem; 2006 Sep; 71(20):7697-705. PubMed ID: 16995676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-phase route to Fmoc-protected cationic amino acid building blocks.
    Clausen JD; Linderoth L; Nielsen HM; Franzyk H
    Amino Acids; 2012 Oct; 43(4):1633-41. PubMed ID: 22358257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the excluded protecting group (EPG) method for peptide synthesis.
    Head DB; Dong JZ; Burton JA
    J Pept Res; 2005 Mar; 65(3):384-94. PubMed ID: 15787969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of an aspartic acid-containing protected peptide. Alternatives for overcoming a side reaction during HF treatment.
    Robles J; Pedroso E; Grandas A
    Int J Pept Protein Res; 1994 Apr; 43(4):359-62. PubMed ID: 8045681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate recognition mechanism of carboxypeptidase Y.
    Nakase H; Murata S; Ueno H; Hayashi R
    Biosci Biotechnol Biochem; 2001 Nov; 65(11):2465-71. PubMed ID: 11791720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The characterization of crude products from solid-phase peptide synthesis by mu-HPLC/fast atom bombardment mass spectrometry.
    McKellop K; Davidson W; Hansen G; Freeman D; Pallai P
    Pept Res; 1991; 4(1):40-6. PubMed ID: 1802236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.